Önal, Burak, et al. “Tocilizumab Treatment Affects Intensive Care Unit Admission Rates of COVID-19 Patients in a Dose-Dependent Manner”. Cerrahpaşa Medical Journal, vol. 45, no. 3, Sept. 2021, pp. 177-84, doi:10.5152/cjm.2021.21057.